Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients with Advanced Cirrhosis or Post-transplant Recurrence: Final Results of the ALLY-1 Study: 2016 ACG Presidential Poster Award: 774

Journal article

Peer reviewed

Fred Poordad, Eugene Schiff, John M Vierling, Charles Landis, Robert J Fontana, Rong Yang, Fiona McPhee, Stephanie Noviello and Eugene S Swenson

The American journal of gastroenterology, Vol.111, p.S346

2016-10

Metrics

1 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients with Advanced Cirrhosis or Post-transplant Recurrence: Final Results of the ALLY-1 Study: 2016 ACG Presidential Poster Award
Creators: Fred Poordad
Eugene Schiff
John M Vierling
Charles Landis
Robert J Fontana
Rong Yang
Fiona McPhee
Stephanie Noviello
Eugene S Swenson
Publication Details: The American journal of gastroenterology, Vol.111, p.S346
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
Record Identifier: 991031598701602976